Use of EphA4 and modulator or EphA4 for diagnosis, treatment and prevention of cancer

Details for Australian Patent Application No. 2004291026 (hide)

International Classifications

Event Publications

2 February 2006 PCT application entered the National Phase

PCT publication WO2005/048917 Priority application(s): WO2005/048917

9 October 2008 Alteration of Name

The name of the applicant has been altered to MedImmune, LLC

8 April 2010 Amendment Made

The nature of the amendment is: Amend the invention title to read Use of EphA4 and modulator of EphA4 for diagnosis, treatment and prevention of cancer

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.